Spots Global Cancer Trial Database for diphenhydramine
Every month we try and update this database with for diphenhydramine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of HLX07,in Patients With Advanced Solid Cancers | NCT02648490 | Solid Tumour | HLX07 Acetaminophen dexamethasone diphenhydramine 5-HT3 inhibitor | 18 Years - | Henlix, Inc | |
| Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment | NCT00324467 | Lymphoma, Non-H... Advanced Stage ... | Cyclophosphamid... Doxorubicin Vincristine Prednisone Ondansetron Dexamethasone Diphenhydramine Acetaminophen Ifosfamide Mesna (IV) Mesna (oral) Carboplatin Etoposide Rituximab Ondansetron Dexamethasone Diphenhydramine Acetaminophen PET Scan | 18 Years - | British Columbia Cancer Agency | |
| BMS 247550 to Treat Kidney Cancer | NCT00030992 | Renal Cell Carc... | BMS-247550 Ranitidine Diphenhydramine | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia | NCT01059786 | Hairy Cell Leuk... | Pentostatin Rituximab Bendamustine Acetaminophen Diphenhydramine Epinephrine Antihistamines Corticosteroids Bronchodilators Intravenous (IV... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology | NCT05977998 | Gastric Adenoca... Carcinomatosis | Paclitaxel Dexamethasone Diphenhydramine Famotidine | 18 Years - | M.D. Anderson Cancer Center | |
| Papillary Serous Carcinoma of the Endometrium | NCT00515073 | Endometrial Can... | Paclitaxel Pelvic Radiatio... Dexamethasone Cimetidine Diphenhydramine | - | M.D. Anderson Cancer Center | |
| Chemotherapy and Locoregional Therapy Trial (Surgery or Radiation) for Patients With Head and Neck Cancer | NCT03107182 | HPV-Related Squ... HNSCC | nab-paclitaxel Carboplatin Nivolumab Cisplatin Hydroxyurea 5-FU Dexamethasone Famotidine Diphenhydramine Paclitaxel Transoral robot... Adjuvant RT Chemoradiothera... | 18 Years - | University of Chicago | |
| KEYMAKER-U01 Substudy 3: Efficacy and Safety Study of Pembrolizumab (MK-3475) When Used With Investigational Agents in Participants With Advanced Non-small Cell Lung Cancer (NSCLC), Previously Treated With Anti-programmed Cell Death Receptor Ligand 1 (PD-L1) Therapy (MK-3475-01C/KEYMAKER-U01C) | NCT04165096 | Carcinoma, Non-... | Pembrolizumab Boserolimab MK-4830 diphenhydramine acetaminophen MK-0482 | 18 Years - | Merck Sharp & Dohme LLC | |
| Feasibility of a Clinical Trial Comparing the Use of Cetirizine to Replace Diphenhydramine in the Prevention of Reactions Related to Paclitaxel | NCT04237090 | Breast Cancer Lung Cancer Ovarian Cancer Oesophageal Can... Head Cancer Nec... Cervical Cancer Endometrial Can... | Diphenhydramine Cetirizine Lactose pill Sodium chloride... | 18 Years - | Ciusss de L'Est de l'Île de Montréal | |
| A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma | NCT04268498 | Multiple Myelom... | Bortezomib Dexamethasone Lenalidomide Acetaminophen Diphenhydramine Montelukast Carfilzomib Daratumumab Autologous Stem... | 18 Years - 75 Years | University of Miami | |
| An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of HLX07,in Patients With Advanced Solid Cancers | NCT02648490 | Solid Tumour | HLX07 Acetaminophen dexamethasone diphenhydramine 5-HT3 inhibitor | 18 Years - | Henlix, Inc | |
| Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies | NCT04681105 | Recurrent Acute... Recurrent B Acu... Recurrent Blast... Recurrent Chron... Recurrent Hairy... Recurrent Hemat... Recurrent Hodgk... Recurrent T Acu... Refractory Acut... Refractory B Ac... Refractory Blas... Refractory Chro... Refractory Hair... Refractory Hema... Refractory Hodg... Refractory T Ac... Systemic Mastoc... | Acetaminophen Dexamethasone Diphenhydramine Flotetuzumab Ibuprofen Ranitidine | 12 Years - | City of Hope Medical Center | |
| Study of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology | NCT03330028 | Diseases of Oes... | Dexamethasone Diphenhydramine Famotidine Mitomycin C Cisplatin Paclitaxel | 18 Years - | M.D. Anderson Cancer Center | |
| Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia | NCT03913559 | Acute Lymphobla... | Inotuzumab ozog... Methotrexate Hydrocortisone Cytarabine Diphenhydramine Acetaminophen Methylprednisol... | - 21 Years | St. Jude Children's Research Hospital | |
| Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma | NCT05896228 | Refractory Mult... Relapsed Multip... | Iberdomide Carfilzomib Daratumumab Dexamethasone Acetaminophen Diphenhydramine Montelukast | 18 Years - 75 Years | University of Miami | |
| Evaluation of SAR408701 in Japanese Patients With Advanced Malignant Solid Tumors | NCT03324113 | Neoplasm Malign... | SAR408701 dexamethasone naphazoline diphenhydramine | 20 Years - | Sanofi | |
| BMS 247550 to Treat Kidney Cancer | NCT00030992 | Renal Cell Carc... | BMS-247550 Ranitidine Diphenhydramine | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Moxetumomab Pasudotox-tdfk (Lumoxiti(TM)) and Either Rituximab (Rituxan(R)) or Ruxience for Relapsed Hairy Cell Leukemia | NCT03805932 | Hairy Cell Leuk... | Moxetumomab Pas... Rituximab Ruxience Dexamethasone Acetaminophen Diphenhydramine Famotidine Aspirin | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma | NCT06356571 | Plasma Cell Mye... | Isatuximab SC-O... Montelukast Dexamethasone Acetaminophen Diphenhydramine Methylprednisol... Carfilzomib | 18 Years - | Sanofi | |
| Morphine Mouthwash for Management of Oral Mucositis in Patients With Head and Neck Cancer | NCT01837446 | Stomatitis | 2% morphine sol... Magnesium alumi... 2% viscous lido... Diphenhydramine | 18 Years - | Isfahan University of Medical Sciences | |
| A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology | NCT05977998 | Gastric Adenoca... Carcinomatosis | Paclitaxel Dexamethasone Diphenhydramine Famotidine | 18 Years - | M.D. Anderson Cancer Center | |
| Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma | NCT05896228 | Refractory Mult... Relapsed Multip... | Iberdomide Carfilzomib Daratumumab Dexamethasone Acetaminophen Diphenhydramine Montelukast | 18 Years - 75 Years | University of Miami | |
| Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC) | NCT01392183 | Kidney Cancer | Pazopanib Temsirolimus Quality of Life... Benadryl | 18 Years - | M.D. Anderson Cancer Center | |
| Intratumor Injection of Anti-Mesothelin Immunotoxin LMB-100 With Ipilimumab in Malignant Mesothelioma | NCT04840615 | Mesothelioma | LMB-100 ipilimumab Diphenhydramine Famotidine Acetaminophen Dexamethasone Biopsy FDG-PET CT CAP MRI ECG Echocardiogram | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
| A Phase I/II Study of Intraperitoneal Paclitaxel in Patients With Metastatic Appendiceal Adenocarcinoma | NCT06207305 | Metastatic Appe... Intraperitoneal... | Dexamethasone Diphenhydramine Famotidine Paclitaxel | 18 Years - | M.D. Anderson Cancer Center | |
| Feasibility of a Clinical Trial Comparing the Use of Cetirizine to Replace Diphenhydramine in the Prevention of Reactions Related to Paclitaxel | NCT04237090 | Breast Cancer Lung Cancer Ovarian Cancer Oesophageal Can... Head Cancer Nec... Cervical Cancer Endometrial Can... | Diphenhydramine Cetirizine Lactose pill Sodium chloride... | 18 Years - | Ciusss de L'Est de l'Île de Montréal | |
| Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia | NCT01059786 | Hairy Cell Leuk... | Pentostatin Rituximab Bendamustine Acetaminophen Diphenhydramine Epinephrine Antihistamines Corticosteroids Bronchodilators Intravenous (IV... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Magic Mouthwash Plus Sucralfate Versus Benzydamine Hydrochloride for the Treatment of Radiation-induced Mucositis | NCT00814359 | Head and Neck C... Mucositis | Combination of ... 0.15% Benzydami... | 18 Years - | Juravinski Cancer Centre Foundation | |
| Morphine Mouthwash for Management of Oral Mucositis in Patients With Head and Neck Cancer | NCT01837446 | Stomatitis | 2% morphine sol... Magnesium alumi... 2% viscous lido... Diphenhydramine | 18 Years - | Isfahan University of Medical Sciences | |
| Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia | NCT03913559 | Acute Lymphobla... | Inotuzumab ozog... Methotrexate Hydrocortisone Cytarabine Diphenhydramine Acetaminophen Methylprednisol... | - 21 Years | St. Jude Children's Research Hospital | |
| Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG | NCT00899847 | Transplantation... Transplantation... Multiple Myelom... Blood and Marro... | Autologous peri... Allogeneic peri... Filgrastim Cyclophosphamid... Melphalan Cyclosporine Total lymphoid ... Rabbit anti-thy... Mycophenolate M... Solumedrol Diphenhydramine Acetaminophen Hydrocortisone | 18 Years - 75 Years | Stanford University | |
| Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood | NCT00923910 | Leukemia, Acute... Leukemia, Acute... Leukemia, Chron... Myelodysplastic... Non-Hodgkin's L... | WT1 Peptide-Pul... Donor Lymphocyt... IL-4 KLH WT1 Peptides Endotoxin Diphenhydramine Acetaminophen | 1 Year - 74 Years | National Institutes of Health Clinical Center (CC) | |
| KEYMAKER-U01 Substudy 3: Efficacy and Safety Study of Pembrolizumab (MK-3475) When Used With Investigational Agents in Participants With Advanced Non-small Cell Lung Cancer (NSCLC), Previously Treated With Anti-programmed Cell Death Receptor Ligand 1 (PD-L1) Therapy (MK-3475-01C/KEYMAKER-U01C) | NCT04165096 | Carcinoma, Non-... | Pembrolizumab Boserolimab MK-4830 diphenhydramine acetaminophen MK-0482 | 18 Years - | Merck Sharp & Dohme LLC | |
| Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD | NCT00186628 | Leukemia, Mast-... Mantle-cell Lym... | Total lymphoid ... Rituximab Anti-thymoglobu... Cyclosporine Mycophenylate m... Filgrastim Granisetron Solumedrol Acetaminophen Diphenhydramine Hydrocortisone | 18 Years - 76 Years | Stanford University | |
| TUSC2-nanoparticles and Erlotinib in Stage IV Lung Cancer | NCT01455389 | Lung Cancer | DOTAP:Chol-TUSC... Erlotinib Dexamethasone Diphenhydramine | 18 Years - | Genprex, Inc. | |
| Study of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology | NCT03330028 | Diseases of Oes... | Dexamethasone Diphenhydramine Famotidine Mitomycin C Cisplatin Paclitaxel | 18 Years - | M.D. Anderson Cancer Center | |
| Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel | NCT04862585 | Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Breast Carcinom... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... | Cimetidine Dexamethasone Diphenhydramine Famotidine Paclitaxel Quality-of-Life... Ranitidine | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| TUSC2-nanoparticles and Erlotinib in Stage IV Lung Cancer | NCT01455389 | Lung Cancer | DOTAP:Chol-TUSC... Erlotinib Dexamethasone Diphenhydramine | 18 Years - | Genprex, Inc. | |
| Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC) | NCT01392183 | Kidney Cancer | Pazopanib Temsirolimus Quality of Life... Benadryl | 18 Years - | M.D. Anderson Cancer Center | |
| Impact of Temsirolimus Therapy on Circulating Tumor Cell Biology In Men With Castration Resistant Metastatic Prostate Cancer | NCT00887640 | Prostate Cancer | Temsirolimus Diphenhydramine | 18 Years - | Duke University | |
| Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel | NCT04862585 | Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Breast Carcinom... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... | Cimetidine Dexamethasone Diphenhydramine Famotidine Paclitaxel Quality-of-Life... Ranitidine | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Morphine Mouthwash for Management of Oral Mucositis in Patients With Head and Neck Cancer | NCT01837446 | Stomatitis | 2% morphine sol... Magnesium alumi... 2% viscous lido... Diphenhydramine | 18 Years - | Isfahan University of Medical Sciences | |
| A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple Myeloma | NCT01998971 | Multiple Myelom... | Daratumumab Velcade Pomalidomide Dexamethasone Melphalan Prednisone Thalidomide Diphenhydramine Acetaminophen Carfilzomib Lenalidomide Montelukast | 18 Years - | Janssen Research & Development, LLC | |
| Phase 2 Study of Bexxar in Relapsed/Refractory DLCL | NCT00490009 | Lymphoma | Bexxar Acetaminophen Diphenhydramine Potassium Iodid... | 19 Years - | Stanford University | |
| Impact of Temsirolimus Therapy on Circulating Tumor Cell Biology In Men With Castration Resistant Metastatic Prostate Cancer | NCT00887640 | Prostate Cancer | Temsirolimus Diphenhydramine | 18 Years - | Duke University | |
| Evaluation of SAR408701 in Japanese Patients With Advanced Malignant Solid Tumors | NCT03324113 | Neoplasm Malign... | SAR408701 dexamethasone naphazoline diphenhydramine | 20 Years - | Sanofi | |
| Study of Ramucirumab (IMC-1121B) Therapy and Corrected QT (QTc) Interval Changes | NCT01017731 | Cancer Solid Tumor | IMC-1121B Moxifloxacin Diphenhydramine | 18 Years - | Eli Lilly and Company | |
| Magic Mouthwash Plus Sucralfate Versus Benzydamine Hydrochloride for the Treatment of Radiation-induced Mucositis | NCT00814359 | Head and Neck C... Mucositis | Combination of ... 0.15% Benzydami... | 18 Years - | Juravinski Cancer Centre Foundation | |
| Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT | NCT00482053 | Lymphoma, B-cel... Lymphoma, Non-H... Diffuse Large B... Malignant Lymph... | Autologous hema... Allogeneic hema... Total lymphoid ... Rituximab Carmustine Etoposide Filgrastim Anti-thymocyte ... Cyclosporine Mycophenolate m... Cyclophosphamid... Acetaminophen Diphenhydramine Hydrocortisone Methylprednisol... | 18 Years - 70 Years | Stanford University | |
| A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma | NCT04268498 | Multiple Myelom... | Bortezomib Dexamethasone Lenalidomide Acetaminophen Diphenhydramine Montelukast Carfilzomib Daratumumab Autologous Stem... | 18 Years - 75 Years | University of Miami | |
| A Phase II Trial of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Chemoradiation | NCT04308837 | Gastric Cancer Stomach Cancer | Paclitaxel Carboplatin Dexamethasone Diphenhydramine Famotidine Palonosetron 3D conformal or... Surgical resect... Adjuvant Chemot... | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment | NCT00324467 | Lymphoma, Non-H... Advanced Stage ... | Cyclophosphamid... Doxorubicin Vincristine Prednisone Ondansetron Dexamethasone Diphenhydramine Acetaminophen Ifosfamide Mesna (IV) Mesna (oral) Carboplatin Etoposide Rituximab Ondansetron Dexamethasone Diphenhydramine Acetaminophen PET Scan | 18 Years - | British Columbia Cancer Agency |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
